A Study to Test How Well Different Doses of BI 4060107 Are Tolerated by People With Advanced Cancer (Solid Tumours) (clinicaltrials.gov) - Sep 18, 2026 - P1 | N=90 | Not yet recruiting | Sponsor: AIMEDBIO
First-in-human • New P1 trial • Oncology • Solid Tumor
|